Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189018 · ClinicalTrials.gov registry record · NA
Activity To Improve Outcomes in Peripheral Arterial Disease
A NA study of Peripheral Arterial Occlusive Disease, sponsored by Baltimore VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT02189018 is a NA study of Peripheral Arterial Occlusive Disease that has completed, run by Baltimore VA Medical Center. The registered enrollment target is 208 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02189018, a NA study of Peripheral Arterial Occlusive Disease, has completed, sponsored by Baltimore VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk. This research project is being implemented in adults with PAD to examine the effects of exercise or weight loss programs on lower extremity blood flow, health, and physical function.
Conditions Studied
Interventions
- OTHER Active Exercise
- OTHER Neuromuscular electrical stimulation
- OTHER Weight loss and active exercise
- OTHER Ad lib activity at home
Study Locations (1)
Maryland
- Baltimore VAMC - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2014-08 |
| Est. Completion | 2023-07-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189018
The ClinicalTrials.gov registry entry for NCT02189018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baltimore VA Medical Center, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Occlusive Disease appearing as the primary indexed condition, and to 4 interventions - of which Active Exercise is the first listed.
NCT02189018 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02189018 about?
NCT02189018 is a clinical study titled "Activity To Improve Outcomes in Peripheral Arterial Disease". Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk...
What is the current status of trial NCT02189018?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2014-08. Estimated completion is 2023-07-04.
What conditions does trial NCT02189018 study?
This clinical trial studies the following conditions: Peripheral Arterial Occlusive Disease.
What interventions are being tested in trial NCT02189018?
The interventions under investigation include: Active Exercise (OTHER), Neuromuscular electrical stimulation (OTHER), Weight loss and active exercise (OTHER), Ad lib activity at home (OTHER).
Who is sponsoring clinical trial NCT02189018?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02189018 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Occlusive Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.